Clinical Trial Update: Bioactive Glass as Bone Graft Substitute in Operative Treatment of Bone - a 10 Years Follow-up Study

View source ↗

Summary

This report summarizes a 10-year follow-up of using bioactive glass as a bone graft substitute in operative bone repair, including depressed lateral condyle fra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Bone Tumor
• Distal Humerus Fracture

Drugs mentioned

• Bioactive Glass

Snippet

Sponsor: Vivoxid Ltd | Conditions: Depressed Lateral Condyle Fracture, Benign Bone Tumour Cavity | Status: COMPLETED